谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Dose Intensification of Subcutaneous Vedolizumab is an Effective and Safe Option in Inflammatory Bowel Disease Patients: Results from the Multicentre OPTI-VEDO Study

P. Wils,R. Altwegg,A. Buisson,L. Vuitton,S. Nancey,N. Richard,M. Fumery,G. Bouguen,L. Guillo,B. Caron,N. Duveau,C. Stefanescu,A. L. Pelletier,C. Reenaers,C. Gilletta,M. Uzzan,N. Arab,D. Laharie,M. Vidon,A. Amiot,C. Le Berre,J. Kirchgesner,O. Dewit, M. Simon,F. Goutorbe,E. Vicaut,L. Peyrin-Biroulet, GETAID Grp

JOURNAL OF CROHNS & COLITIS（2025）

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要